{
  "ptid_time": "128_S_4772_2012-06-13",
  "img_path": "/data/qiuhui/data/adni/images/128_S_4772/2012-06-13/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 53,194 mm³, 89.5% above the reference mean. With a Z-score of 2.05 (98.0th percentile), this represents significant enlargement; hippocampal volume measures 5,552 mm³, 22.0% below the reference mean. With a Z-score of -2.01 (2.2th percentile), this represents significant atrophy; whole brain volume measures 915,569 mm³, 6.1% below the reference mean. With a Z-score of -0.76 (22.3th percentile), this represents normal volume ; entorhinal cortex volume measures 2,569 mm³, 30.1% below the reference mean. With a Z-score of -1.84 (3.3th percentile), this represents moderate atrophy; fusiform gyrus volume measures 14,939 mm³, 12.2% below the reference mean. With a Z-score of -1.11 (13.4th percentile), this represents mild atrophy; middle temporal gyrus volume measures 14,738 mm³, 23.1% below the reference mean. With a Z-score of -2.01 (2.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 78.7 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Psychiatric; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 20.0. MoCA: 17.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.12 SUVR (normal ). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant hippocampal and middle temporal gyrus atrophy, along with moderate entorhinal cortex atrophy—key regions affected in Alzheimer's disease. The cognitive scores (MMSE 20, MoCA 17) indicate moderate impairment, consistent with dementia rather than MCI. The absence of APOE4 and normal AV45 (amyloid PET) suggests possible non-amyloid pathology, but the structural and cognitive findings strongly support neurodegeneration.  \n\n**Diagnosis:** Dementia (likely Alzheimer’s disease or a non-amyloid neurodegenerative subtype)  \n**Confidence:** Medium (due to atypical biomarker profile but clear structural/cognitive deficits)",
  "timestamp": "2025-07-26T14:05:20.881634"
}